Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -82,339 | -32,011 | -70,691 | -15,863 |
| Depreciation Amortization | N/A | 2,397 | 1,309 | 17,409 | 13,557 |
| Income taxes - deferred | N/A | -158 | -129 | -10,617 | -3,272 |
| Accounts receivable | N/A | 582 | -1,245 | 8,195 | 8,815 |
| Accounts payable and accrued liabilities | N/A | 843 | 2,554 | 4,191 | 113 |
| Other Working Capital | N/A | -22,817 | -17,179 | -9,761 | 259 |
| Other Operating Activity | 0 | 66,033 | 31,447 | 28,831 | -16,908 |
| Operating Cash Flow | $N/A | $-35,459 | $-15,254 | $-32,443 | $-13,299 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -235 | -93 | -763 | -504 |
| Purchase Of Investment | N/A | N/A | N/A | -60,000 | -60,000 |
| Purchase Sale Intangibles | N/A | 0 | N/A | 82,572 | 61,590 |
| Other Investing Activity | 0 | 24,966 | 0 | 82,572 | 61,590 |
| Investing Cash Flow | $N/A | $24,731 | $-93 | $21,809 | $1,086 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -18,845 | -18,845 | -97,889 | N/A |
| Common Stock Issued | N/A | 461 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -39,374 | -19,226 | -86,898 | -75,891 |
| Dividend Paid | N/A | N/A | N/A | -9 | N/A |
| Other Financing Activity | 0 | -3,020 | -2,661 | -5,709 | -12,216 |
| Financing Cash Flow | $N/A | $-60,778 | $-40,732 | $-190,505 | $-88,107 |
| Beginning Cash Position | N/A | 193,451 | 193,451 | 394,590 | 394,590 |
| End Cash Position | N/A | 141,820 | 137,372 | 193,451 | 294,270 |
| Net Cash Flow | $N/A | $-51,631 | $-56,079 | $-201,139 | $-100,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -35,459 | -15,254 | -32,443 | -13,299 |
| Capital Expenditure | N/A | -235 | -93 | -763 | -504 |
| Free Cash Flow | 0 | -35,694 | -15,347 | -33,206 | -13,803 |